
Aravive ARAV
Quartalsbericht 2023-Q3
hinzugefügt 09.11.2023
Aravive Kurzfristige Verbindlichkeiten 2011-2026 | ARAV
Kurzfristige Verbindlichkeiten Jährlich Aravive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.1 M | 17.9 M | 9.46 M | 4.97 M | 1.94 M | 5.59 M | - | 8.83 M | 6.92 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22.1 M | 1.94 M | 9.72 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
98.1 M | $ 18.46 | -0.22 % | $ 2.72 B | ||
|
Amgen
AMGN
|
23.1 B | $ 344.63 | 0.8 % | $ 185 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
195 M | $ 70.06 | 1.05 % | $ 9.37 B | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Biogen
BIIB
|
5.53 B | $ 179.46 | -0.24 % | $ 26.1 B | ||
|
Aytu BioScience
AYTU
|
63.1 M | $ 2.7 | 3.85 % | $ 17 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
38.2 M | $ 2.6 | -5.45 % | $ 146 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.05 M | $ 4.32 | 7.67 % | $ 9.4 B | ||
|
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
4.46 M | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | ||
|
Compugen Ltd.
CGEN
|
20.2 M | $ 1.83 | -0.3 % | $ 164 M | ||
|
Aeglea BioTherapeutics
AGLE
|
54.1 M | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
99.9 M | $ 1.41 | - | $ 264 M | ||
|
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | ||
|
Celldex Therapeutics
CLDX
|
39.5 M | $ 24.98 | 1.54 % | $ 1.61 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | ||
|
Athira Pharma
ATHA
|
13.1 M | - | - | $ 269 M | ||
|
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.38 | 0.73 % | $ 352 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
141 M | $ 42.1 | 5.59 % | $ 4.35 B | ||
|
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
121 M | $ 24.77 | 1.93 % | $ 2.93 B | ||
|
Cardiff Oncology
CRDF
|
13.4 M | $ 1.7 | -3.14 % | $ 81 M | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
72.8 M | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.13 B | $ 13.96 | 2.01 % | $ 4.31 B | ||
|
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
16.3 M | - | -11.76 % | $ 5.79 M | ||
|
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
160 M | $ 6.58 | - | $ 1.36 B |